← All companies
Terns Pharmaceuticals, Inc.
TERN - CIK 0001831363
Market cap$6.12 B
Rank#1249
SEC filings430
The table below shows Terns Pharmaceuticals, Inc.'s balance sheet line items across its last 5 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Cash & equivalents | $524.75M | $161.44M | $79.93M | $143.24M | $47.70M |
| Short-term investments | $494.24M | $196.72M | $183.51M | $139.88M | $118.28M |
| Receivables | - | - | - | - | - |
| Inventory | - | - | - | - | - |
| Total current assets | $1.02B | $362.11M | $267.43M | $285.19M | $166.93M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.